Related references
Note: Only part of the references are listed.MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators
Bojan Ljepoja et al.
BREAST (2019)
Exosome-derived miR-27a produced by PSC-27 cells contributes to prostate cancer chemoresistance through p53
Zhigang Cao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway
Yu Mu et al.
BIOSCIENCE REPORTS (2019)
被撤回的出版物: Relationship between microRNA-27a and efficacy of neoadjuvant chemotherapy in gastric cancer and its mechanism in gastric cancer cell growth and metastasis (Retracted article. See vol. 41, 2021)
Chunlei Xu et al.
BIOSCIENCE REPORTS (2019)
miR-27a-3p regulates proliferation and apoptosis of colon cancer cells by potentially targeting BTG1
Chang Su et al.
ONCOLOGY LETTERS (2019)
MiR-27a promotes EMT in ovarian cancer through active Wnt/β-catenin signalling by targeting FOXO1
Li-Ya Zhang et al.
CANCER BIOMARKERS (2019)
Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional regulation of gene expression
Mengfan Pu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Anthracycline-induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment
Fengfeng Cai et al.
MOLECULAR AND CLINICAL ONCOLOGY (2019)
BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells
Ke-Hung Tsui et al.
CANCER MEDICINE (2018)
Circulating Exosomal miR-27a and miR-130a Act as Novel Diagnostic and Prognostic Biomarkers of Colorectal Cancer
Xiangxiang Liu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
Breast Cancer, Version 4.2017 Clinical Practice Guidelines in Oncology
William J. Gradishar et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
MIR-27a regulates the TGF- signaling pathway by targeting SMAD2 and SMAD4 in lung cancer
Dong-Kyu Chae et al.
MOLECULAR CARCINOGENESIS (2017)
In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway
Ling-Yu Kong et al.
ONCOTARGET (2017)
Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer
Yufei Zhou et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
microRNAs as cancer therapeutics: A step closer to clinical application
Tina Catela Ivkovic et al.
CANCER LETTERS (2017)
miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis
Sumei Zhou et al.
TUMOR BIOLOGY (2016)
Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance
Katia Danza et al.
CANCER BIOLOGY & THERAPY (2016)
New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy
Alberto A. Gabizon et al.
DRUG RESISTANCE UPDATES (2016)
Integrated molecular analysis to investigate the role of microRNAs in pancreatic tumour growth and progression
Adam E Frampton et al.
LANCET (2015)
MiR-27a Modulates Radiosensitivity of Triple-Negative Breast Cancer (TNBC) Cells by Targeting CDC27
Jianjun Han
MEDICAL SCIENCE MONITOR (2015)
miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells
Jipeng Li et al.
MOLECULAR CANCER (2014)
miR-27a regulates endothelial differentiation of breast cancer stem like cells
W. Tang et al.
ONCOGENE (2014)
MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells
A. Formosa et al.
ONCOGENE (2014)
B-cell translocation gene 2 mediates crosstalk between PI3K/Akt1 and NFκB pathways which enhances transcription of MnSOD by accelerating I.Ba degradation in normal and cancer cells
Santhoshkumar Sundaramoorthy et al.
CELL COMMUNICATION AND SIGNALING (2013)
MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells
Zhaolin Chen et al.
CELLULAR SIGNALLING (2013)
BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells
Yan-jun Zhang et al.
TUMOR BIOLOGY (2013)
Effects of BTG2 on proliferation inhibition and anti-invasion in human lung cancer cells
Sen Wei et al.
TUMOR BIOLOGY (2012)
Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia
Dan-Dan Feng et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells
Xiaohong Zhao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARγ expression
Sang Yun Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray
Elin Mollerstrom et al.
BMC CANCER (2010)
MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells
Zhimin Li et al.
GYNECOLOGIC ONCOLOGY (2010)
The Mammalian Anti-Proliferative BTG/Tob Protein Family
G. Sebastiaan Winkler
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Chemotherapy for breast cancer (Review)
M. S. U. Hassan et al.
ONCOLOGY REPORTS (2010)
Expression of the NF-κB-responsive gene BTG2 is aberrantly regulated in breast cancer
H Kawakubo et al.
ONCOGENE (2004)
Share Paper
